<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02645227</url>
  </required_header>
  <id_info>
    <org_study_id>GDCRI/ACM/PG/PhD/12/2013-14V</org_study_id>
    <nct_id>NCT02645227</nct_id>
  </id_info>
  <brief_title>Platelet-rich Fibrin With 1.2% Rosuvastatin in Chronic Periodontitis Treatment</brief_title>
  <official_title>Platelet-rich Fibrin With 1.2% Rosuvastatin for the Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Government Dental College and Research Institute, Bangalore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Government Dental College and Research Institute, Bangalore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study is designed to evaluate the combined efficacy of Platelet Rich Fibrin (PRF)
      and 1.2% Rosuvastatin (RSV) with open flap debridement (OFD) in treatment of intrabony
      defects in chronic periodontitis patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ABSTRACT Background: Regenerative periodontal therapy encompasses the use of various
      bioactive agents that are not only inflammo-modulatory but also osteoclast-inhibitory or
      rather, osteostimulative. The hypolipidaemic Statin group of drugs, particularly Rosuvastatin
      (RSV), are known to be associated with alveolar bone formation and periodontal improvements.
      Platelet analogues like Platelet rich fibrin (PRF), being rich sources of growth factors,
      have also come into widespread periodontal regenerative use. The aim of the study is to
      evaluate and compare the efficacy of open-ﬂap debridement (OFD) with or without PRF or PRF +
      1.2% RSV gel in the treatment of intrabony defects (IBDs) in chronic periodontitis (CP)
      patients.

      Methods: Ninety individuals with a total of 90 IBDs were randomly assigned to one of the 3
      treatment groups: 1) OFD alone, 2) OFD + PRF and 3) OFD + PRF + 1.2% RSV gel placement.
      Plaque index (PI), modified sulcus bleeding index (mSBI), probing depth (PD), clinical
      attachment (CA) level and IBD depth were recorded at baseline and at 9 months
      post-operatively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>defect depth reduction (%)</measure>
    <time_frame>Change from baseline to 9 months</time_frame>
    <description>assessed in percentage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>probing depth (mm)</measure>
    <time_frame>Change from baseline to 9 months</time_frame>
    <description>measured in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinical attachment level (mm)</measure>
    <time_frame>Change from baseline to 9 months</time_frame>
    <description>measured in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified sulcus bleeding index</measure>
    <time_frame>Change from baseline to 9 months</time_frame>
    <description>scale from 0-3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plaque index</measure>
    <time_frame>Change from baseline to 9 months</time_frame>
    <description>scale from 0-3</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open flap debridement (OFD)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>OFD with Platelet rich fibrin (PRF)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>OFD with PRF and 1.2% Rosuvastatin</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open flap debridement (OFD)</intervention_name>
    <description>Oral prophylaxis followed by OFD for treating bone defect</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OFD with Platelet rich fibrin (PRF)</intervention_name>
    <description>Oral prophylaxis followed by OFD with PRF placement into the bone defect</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OFD with PRF and 1.2% Rosuvastatin</intervention_name>
    <description>Oral prophylaxis followed by OFD with PRF and 1.2% Rosuvastatin placement into the bone defect</description>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Systemically healthy with CP diagnosis16 having probing depth (PD) ≥5mm, clinical
             attachment (CA) level ≥3mm and vertical bone loss ≥3mm on intraoral periapical
             radiographs (IOPAR) without any antibiotic or periodontal therapy in the last 6
             months.

        Exclusion Criteria:

          -  History of statin allergy, statin therapy, any systemic condition or medication
             altering the periodontal condition, immune-compromised state, hematologic disorders,
             insufﬁcient platelet count (&lt;200,000/mm3), aggressive periodontitis, substance/tobacco
             abuse and lactating and pregnant females.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avani Pradeep, MDS</last_name>
    <role>Study Director</role>
    <affiliation>Government Dental Colleege &amp; Research Institute, Bangalore</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Government Dental College and Research Institute</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2015</study_first_submitted>
  <study_first_submitted_qc>December 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 1, 2016</study_first_posted>
  <last_update_submitted>January 1, 2016</last_update_submitted>
  <last_update_submitted_qc>January 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Government Dental College and Research Institute, Bangalore</investigator_affiliation>
    <investigator_full_name>Dr. A R Pradeep</investigator_full_name>
    <investigator_title>Professor and Head, Department of Periodontology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rosuvastatin Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

